Tag: Stephen Hurst

0 1354

MindMed streamlines leadership with further emphasis on integrating psychedelic drug development with digital medicines and therapeutics

J.R. Rahn to become sole CEO; Perry Dellelce to become Chair; Stephen Hurst retires as executive but remains on…

 Leave a comment    Posted in Psychedelics Tagged , , , , ,